Cargando…

Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies

BACKGROUND: One third of travellers to low- and middle-income regions of the tropics and subtropics become colonized by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE). The risk varies by destination and, for each traveller, may be substantially further increased by traveller...

Descripción completa

Detalles Bibliográficos
Autores principales: Lääveri, Tinja, Vlot, Jessica A., van Dam, Alje P., Häkkinen, Hanni K., Sonder, Gerard J. B., Visser, Leo G., Kantele, Anu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057027/
https://www.ncbi.nlm.nih.gov/pubmed/30037325
http://dx.doi.org/10.1186/s12879-018-3245-z
_version_ 1783341442332098560
author Lääveri, Tinja
Vlot, Jessica A.
van Dam, Alje P.
Häkkinen, Hanni K.
Sonder, Gerard J. B.
Visser, Leo G.
Kantele, Anu
author_facet Lääveri, Tinja
Vlot, Jessica A.
van Dam, Alje P.
Häkkinen, Hanni K.
Sonder, Gerard J. B.
Visser, Leo G.
Kantele, Anu
author_sort Lääveri, Tinja
collection PubMed
description BACKGROUND: One third of travellers to low- and middle-income regions of the tropics and subtropics become colonized by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE). The risk varies by destination and, for each traveller, may be substantially further increased by travellers’ diarrhoea (TD) and antibiotic use. Despite the risk of TD in Africa, ESBL-PE acquisition rates in all studies are lower there than in Asia. Africa has become increasingly popular as a destination for international travellers, yet minimal data are available from the continent’s subregions and countries. METHODS: We analysed subregion- and country-specific data on carriage and risk factors for ESBL-PE colonization pooled from three prospective studies conducted between 2009 and 2013 among Finnish and Dutch travellers. The data were subjected to multivariable analysis of risk factors. In addition, we compared our data to two recent large investigations reporting data by subregion and country. RESULTS: Our joint analysis comprised data on 396 travellers. The ESBL-PE colonization rate was highest in Northern Africa, followed by Middle and Eastern Africa, and lowest in Southern and Western Africa. Of individual countries with more than 15 visitors, the highest rates were seen for Egypt (12/17; 70.6%), Ghana (6/23; 26.1%), and Tanzania (14/81; 17.3%); the rates among travellers to Egypt were comparable to those reported in South and Southeast Asia. In a pooled multivariable analysis, travel destination, age, overnight hospitalisation abroad, TD, and use of fluoroquinolones were independently associated with increased ESBL-PE colonization rates. CONLUSIONS: Even in areas with relatively low risk of colonization, antimicrobials clearly predispose to colonization with ESBL-PE. Travellers to Africa should be cautioned against unnecessary use of antibiotics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3245-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6057027
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60570272018-07-30 Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies Lääveri, Tinja Vlot, Jessica A. van Dam, Alje P. Häkkinen, Hanni K. Sonder, Gerard J. B. Visser, Leo G. Kantele, Anu BMC Infect Dis Research Article BACKGROUND: One third of travellers to low- and middle-income regions of the tropics and subtropics become colonized by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE). The risk varies by destination and, for each traveller, may be substantially further increased by travellers’ diarrhoea (TD) and antibiotic use. Despite the risk of TD in Africa, ESBL-PE acquisition rates in all studies are lower there than in Asia. Africa has become increasingly popular as a destination for international travellers, yet minimal data are available from the continent’s subregions and countries. METHODS: We analysed subregion- and country-specific data on carriage and risk factors for ESBL-PE colonization pooled from three prospective studies conducted between 2009 and 2013 among Finnish and Dutch travellers. The data were subjected to multivariable analysis of risk factors. In addition, we compared our data to two recent large investigations reporting data by subregion and country. RESULTS: Our joint analysis comprised data on 396 travellers. The ESBL-PE colonization rate was highest in Northern Africa, followed by Middle and Eastern Africa, and lowest in Southern and Western Africa. Of individual countries with more than 15 visitors, the highest rates were seen for Egypt (12/17; 70.6%), Ghana (6/23; 26.1%), and Tanzania (14/81; 17.3%); the rates among travellers to Egypt were comparable to those reported in South and Southeast Asia. In a pooled multivariable analysis, travel destination, age, overnight hospitalisation abroad, TD, and use of fluoroquinolones were independently associated with increased ESBL-PE colonization rates. CONLUSIONS: Even in areas with relatively low risk of colonization, antimicrobials clearly predispose to colonization with ESBL-PE. Travellers to Africa should be cautioned against unnecessary use of antibiotics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3245-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-23 /pmc/articles/PMC6057027/ /pubmed/30037325 http://dx.doi.org/10.1186/s12879-018-3245-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lääveri, Tinja
Vlot, Jessica A.
van Dam, Alje P.
Häkkinen, Hanni K.
Sonder, Gerard J. B.
Visser, Leo G.
Kantele, Anu
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies
title Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies
title_full Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies
title_fullStr Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies
title_full_unstemmed Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies
title_short Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies
title_sort extended-spectrum beta-lactamase-producing enterobacteriaceae (esbl-pe) among travellers to africa: destination-specific data pooled from three european prospective studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057027/
https://www.ncbi.nlm.nih.gov/pubmed/30037325
http://dx.doi.org/10.1186/s12879-018-3245-z
work_keys_str_mv AT laaveritinja extendedspectrumbetalactamaseproducingenterobacteriaceaeesblpeamongtravellerstoafricadestinationspecificdatapooledfromthreeeuropeanprospectivestudies
AT vlotjessicaa extendedspectrumbetalactamaseproducingenterobacteriaceaeesblpeamongtravellerstoafricadestinationspecificdatapooledfromthreeeuropeanprospectivestudies
AT vandamaljep extendedspectrumbetalactamaseproducingenterobacteriaceaeesblpeamongtravellerstoafricadestinationspecificdatapooledfromthreeeuropeanprospectivestudies
AT hakkinenhannik extendedspectrumbetalactamaseproducingenterobacteriaceaeesblpeamongtravellerstoafricadestinationspecificdatapooledfromthreeeuropeanprospectivestudies
AT sondergerardjb extendedspectrumbetalactamaseproducingenterobacteriaceaeesblpeamongtravellerstoafricadestinationspecificdatapooledfromthreeeuropeanprospectivestudies
AT visserleog extendedspectrumbetalactamaseproducingenterobacteriaceaeesblpeamongtravellerstoafricadestinationspecificdatapooledfromthreeeuropeanprospectivestudies
AT kanteleanu extendedspectrumbetalactamaseproducingenterobacteriaceaeesblpeamongtravellerstoafricadestinationspecificdatapooledfromthreeeuropeanprospectivestudies